Compare MYSZ & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | PRPO |
|---|---|---|
| Founded | 1999 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 42.0M |
| IPO Year | 2017 | 2000 |
| Metric | MYSZ | PRPO |
|---|---|---|
| Price | $1.69 | $23.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 674.9K | 126.4K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.40 | ★ 92.15 |
| EPS | N/A | ★ N/A |
| Revenue | $142,000.00 | ★ $24,049,000.00 |
| Revenue This Year | $41.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 125.40 | 29.77 |
| 52 Week Low | $0.33 | $16.40 |
| 52 Week High | $4.28 | $33.63 |
| Indicator | MYSZ | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 35.08 |
| Support Level | $0.47 | $22.04 |
| Resistance Level | $2.60 | $24.95 |
| Average True Range (ATR) | 0.24 | 1.28 |
| MACD | -0.07 | -0.50 |
| Stochastic Oscillator | 3.48 | 0.80 |
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.